| Literature DB >> 3136118 |
R Voth1, S Rossol, G Hess, H P Laubenstein, K H Meyer zum Büschenfelde, H C Schröder, M Bachmann, P Reuter, W E Müller.
Abstract
Avarol is a cytostatic and anti-human immunodeficiency virus (HIV) agent. In this study, the avarol caused induction of gamma-interferon (IFN-gamma) in buffy coat cells (human peripheral blood lymphocytes) is demonstrated by immunological and molecular biological techniques. IFN-gamma production was detected after a 24-hr incubation period with avarol; maximal production was obtained after 5 days in the presence of the optimal avarol concentration of 0.75 microgram/ml. Blotting experiments using human IFN-gamma cDNA and beta-actin cDNA containing plasmids showed that in the absence of avarol no IFN-gamma transcripts were present in lymphocytes. Already after a 24-hr incubation with avarol, IFN-gamma gene induction was detected, and maximal induction was found after a 5-day incubation period. The enhanced IFN-gamma production seems to be caused by a change at the transcriptional and/or post-transcriptional level, but not during subsequent nucleocytoplasmic transport of mRNA. This molecular event is specific, at least in relation to the expression of the beta-actin gene. Our studies demonstrate that avarol displays, besides its potential anti-tumor and anti-HIV activity, a potential immunomodulating effect.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3136118 PMCID: PMC5917560 DOI: 10.1111/j.1349-7006.1988.tb00035.x
Source DB: PubMed Journal: Jpn J Cancer Res ISSN: 0910-5050